About Index Trending news
Analyze
Top 50 Pricing
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

Work at Sorrento Therapeutics, Inc.? Add yourself to this profile

Sorrento Therapeutics, Inc.

Sorrento Therapeutics is focused on the development of proprietary drugtherapeutics for addressing unmet medical needs.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Post-IPO equity
$150,000,000
Ally Bridge Group
Employees

Unknown size

Locations
HQ
$150,000,000 Post-IPO equity
http://www.avcj.com

Ally Bridge leads $150m round for US cancer treatment firm | AVCJ